Application 202288

Type
ANDA
Sponsor
MYLAN PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LITHIUM CARBONATELITHIUM CARBONATETABLET, EXTENDED RELEASE;ORAL300MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0378-1300Lithium Carbonatelithium carbonateMylan Pharmaceuticals Inc.ANDACurrent
0378-1300Lithium Carbonatelithium carbonateMylan Pharmaceuticals Inc.ANDACurrent
50090-6052Lithium Carbonatelithium carbonateA-S Medication SolutionsANDACurrent
51079-180Lithium Carbonatelithium carbonateMylan Institutional Inc.ANDACurrent
51079-180Lithium Carbonatelithium carbonateMylan Institutional Inc.ANDACurrent
51079-180Lithium Carbonatelithium carbonateMylan Institutional Inc.ANDACurrent
51079-180Lithium Carbonatelithium carbonateMylan Institutional Inc.ANDACurrent
70518-0360Lithium Carbonatelithium carbonateREMEDYREPACK INC.ANDACurrent
70518-0904Lithium Carbonatelithium carbonateREMEDYREPACK INC.ANDACurrent
70518-0904Lithium Carbonatelithium carbonateREMEDYREPACK INC.ANDACurrent
70518-0904Lithium Carbonatelithium carbonateREMEDYREPACK INC.ANDACurrent
70518-0904Lithium Carbonatelithium carbonateREMEDYREPACK INC.ANDACurrent
70518-0904Lithium Carbonatelithium carbonateREMEDYREPACK INC.ANDACurrent